Causes of Imbalance and Abnormal Gait That May Be Misdiagnosed

Abstract

Disorders of gait and balance are common in medicine and often lead to referral for neurologic evaluation. Because the maintenance of balance and normal gait are mediated by complex neurologic pathways as well as musculoskeletal, metabolic, and behavioral considerations, the list of possible contributing causes is very large. Much of the time, the history and neurologic examination reveal the underlying cause or causes. There are instances, however, when there are limited neurologic findings, as well as no structural abnormalities on brain or spine magnetic resonance imaging studies to explain the imbalance or gait difficulty. In this article, selected disorders that may be overlooked in the neurologic examination and imaging studies are reviewed. Possible causes of imbalance include occult drug-induced ataxia, autoimmune ataxia, ataxia associated with tremor, bilateral vestibular hypofunction, and spastic or dystonic gait disorders with normal imaging.

Keywords

Segawa's disease - gait difficulty - imbalance - ataxia - gluten ataxia - bilateral vestibular loss - essential tremor

• References

• 1 Verghese J, LeValley A, Hall CB, Katz MJ, Ambrose AF, Lipton RB. Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc 2006; 54 (2) 255-261
• 2 Thurman DJ, Stevens JA, Rao JK. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2008; 70 (6) 473-479
• 3 Sirven JI, Fife TD, Wingerchuk DM, Drazkowski JF. Second-generation antiepileptic drugs' impact on balance: a meta-analysis. Mayo Clin Proc 2007; 82 (1) 40-47
• 4 Lang EJ, Davis SM. Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels. J Clin Neurosci 2002; 9 (3) 308-309
• 5 Nagaraja D, Taly AB, Sahu RN, Channabasavanna SM, Narayanan HS. Permanent neurological sequelae due to lithium toxicity. Clin Neurol Neurosurg 1987; 89 (1) 31-34
• 6 Schou M. Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 1984; 70 (6) 594-602
• 7 Karas BJ, Wilder BJ, Hammond EJ, Bauman AW. Valproate tremors. Neurology 1982; 32 (4) 428-432
• 8 Armon C, Shin C, Miller P , et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996; 47 (3) 626-635
• 9 Shill HA, Fife TD. Valproic acid toxicity mimicking multiple system atrophy. Neurology 2000; 55 (12) 1936-1937
• 10 Thome-Souza S, Moreira B, Valente KD. Late adverse effects of the coadministration of valproate and lamotrigine. Pediatr Neurol 2012; 47 (1) 47-50
• 11 Hindle JV, Ibrahim A, Ramaraj R. Ataxia caused by amiodarone in older people. Age Ageing 2008; 37 (3) 347-348
• 12 Raeder EA, Podrid PJ, Lown B. Side effects and complications of amiodarone therapy. Am Heart J 1985; 109 (5 Pt 1) 975-983
• 13 Krauser DG, Segal AZ, Kligfield P. Severe ataxia caused by amiodarone. Am J Cardiol 2005; 96 (10) 1463-1464
• 14 Willis MS, Lugo AM. Amiodarone-induced neurotoxicity. Am J Health Syst Pharm 2009; 66 (6) 567-569
• 15 Hain TC, Cherchi M, Yacovino DA. Bilateral vestibular loss. Semin Neurol 2013; ; 33(3)
• 16 Porciuncula F, Johnson CC, Glickman LB. The effect of vestibular rehabilitation on adults with bilateral vestibular hypofunction: a systematic review. J Vestib Res 2012; 22 (5-6) 283-298
• 17 Louis ED, Marder K, Cote L , et al. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol 1995; 52 (12) 1201-1205
• 18 Rautakorpi I, Takala J, Marttila RJ, Sievers K, Rinne UK. Essential tremor in a Finnish population. Acta Neurol Scand 1982; 66 (1) 58-67
• 19 Dogu O, Sevim S, Camdeviren H , et al. Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology 2003; 61 (12) 1804-1806
• 20 Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor. Mov Disord 1994; 9 (2) 193-196
• 21 Colebatch JG, Findley LJ, Frackowiak RS, Marsden CD, Brooks DJ. Preliminary report: activation of the cerebellum in essential tremor. Lancet 1990; 336 (8722) 1028-1030
• 22 Hallett M, Dubinsky RM. Glucose metabolism in the brain of patients with essential tremor. J Neurol Sci 1993; 114 (1) 45-48
• 23 Jenkins IH, Bain PG, Colebatch JG , et al. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol 1993; 34 (1) 82-90
• 24 Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G. The gait disorder of advanced essential tremor. Brain 2001; 124 (Pt 11) 2278-2286
• 25 Klebe S, Stolze H, Grensing K, Volkmann J, Wenzelburger R, Deuschl G. Influence of alcohol on gait in patients with essential tremor. Neurology 2005; 65 (1) 96-101
• 26 Fasano A, Herzog J, Raethjen J , et al. Gait ataxia in essential tremor is differentially modulated by thalamic stimulation. Brain 2010; 133 (Pt 12) 3635-3648
• 27 Heilman KM. Orthostatic tremor. Arch Neurol 1984; 41 (8) 880-881
• 28 Gerschlager W, Brown P. Orthostatic tremor - a review. Handb Clin Neurol 2011; 100: 457-462
• 29 Brown P. New clinical sign for orthostatic tremor. Lancet 1995; 346 (8970) 306-307
• 30 FitzGerald PM, Jankovic J. Orthostatic tremor: an association with essential tremor. Mov Disord 1991; 6 (1) 60-64
• 31 Rodrigues JP, Edwards DJ, Walters SE , et al. Blinded placebo crossover study of gabapentin in primary orthostatic tremor. Mov Disord 2006; 21 (7) 900-905
• 32 Dombrowski C, Lévesque S, Morel ML, Rouillard P, Morgan K, Rousseau F. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 2002; 11 (4) 371-378
• 33 Jacquemont S, Hagerman RJ, Leehey MA , et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 2004; 291 (4) 460-469
• 34 Deng H, Le W, Jankovic J. Premutation alleles associated with Parkinson disease and essential tremor. JAMA 2004; 292 (14) 1685-1686
• 35 Tan EK, Zhao Y, Puong KY , et al. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 2004; 63 (2) 362-363
• 36 Van Esch H, Dom R, Bex D , et al. Screening for FMR-1 premutations in 122 older Flemish males presenting with ataxia. Eur J Hum Genet 2005; 13 (1) 121-123
• 37 Berry-Kravis E, Abrams L, Coffey SM , et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord 2007; 22 (14) 2018-2030 , quiz 2140
• 38 Jen JC. Genetics of vestibulopathies. Adv Otorhinolaryngol 2011; 70: 130-134
• 39 Paulson HL. The spinocerebellar ataxias. J Neuroophthalmol 2009; 29 (3) 227-237
• 40 Zhuchenko O, Bailey J, Bonnen P , et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997; 15 (1) 62-69
• 41 Jen JC. Genetics of vestibulopathies. Adv Otorhinolaryngol 2011; 70: 130-134
• 42 Watanabe H, Tanaka F, Matsumoto M , et al. Frequency analysis of autosomal dominant cerebellar ataxias in Japanese patients and clinical characterization of spinocerebellar ataxia type 6. Clin Genet 1998; 53 (1) 13-19
• 43 Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 2004; 62 (9) 1623-1625
• 44 Harding AE, Matthews S, Jones S, Ellis CJ, Booth IW, Muller DP. Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med 1985; 313 (1) 32-35
• 45 Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease. Brain 1966; 89 (4) 683-722
• 46 Hadjivassiliou M, Grünewald RA, Chattopadhyay AK , et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 1998; 352 (9140) 1582-1585
• 47 Hadjivassiliou M, Rao DG, Wharton SB, Sanders DS, Grünewald RA, Davies-Jones AG. Sensory ganglionopathy due to gluten sensitivity. Neurology 2010; 75 (11) 1003-1008
• 48 Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness?. Lancet 1996; 347 (8998) 369-371
• 49 Bürk K, Bösch S, Müller CA , et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 2001; 124 (Pt 5) 1013-1019
• 50 Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001; 49 (4) 540-543
• 51 Pellecchia MT, Scala R, Filla A, De Michele G, Ciacci C, Barone P. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry 1999; 66 (1) 32-35
• 52 Hadjivassiliou M, Davies-Jones GA, Sanders DS, Grünewald RA. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry 2003; 74 (9) 1221-1224
• 53 Pellecchia MT, Scala R, Perretti A , et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet. Neurology 1999; 53 (7) 1606-1608
• 54 Nanri K, Okita M, Takeguchi M , et al. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med 2009; 48 (10) 783-790
• 55 Selim M, Drachman DA. Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis. J Neurol Neurosurg Psychiatry 2001; 71 (1) 81-87
• 56 Nakagawa H, Yoneda M, Fujii A, Kinomoto K, Kuriyama M. Hashimoto encephalopathy presenting with progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 2007; 78 (2) 196-197
• 57 Jaeckle KA, Graus F, Houghton A, Cardon-Cardo C, Nielsen SL, Posner JB. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol 1985; 18 (5) 592-600
• 58 Anderson NE, Budde-Steffen C, Rosenblum MK , et al. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) 1988; 67 (2) 100-109
• 59 Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu—associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992; 71 (2) 59-72
• 60 Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14: 215-233
• 61 Deonna T. DOPA-sensitive progressive dystonia of childhood with fluctuations of symptoms—Segawa's syndrome and possible variants. Results of a collaborative study of the European Federation of Child Neurology Societies (EFCNS). Neuropediatrics 1986; 17 (2) 81-85
• 62 Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990; 40 (1) 66-69
• 63 Tadic V, Kasten M, Brüggemann N, Stiller S, Hagenah J, Klein C. Dopa-Responsive Dystonia Revisited: Diagnostic Delay, Residual Signs, and Nonmotor Signs. Arch Neurol 2012; 1-5
• 64 Bandmann O, Valente EM, Holmans P , et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 1998; 44 (4) 649-656
• 65 Bradac GB, Daniele D, Riva A , et al. Spinal dural arteriovenous fistulas: an underestimated cause of myelopathy. Eur Neurol 1994; 34 (2) 87-94
• 66 Toossi S, Josephson SA, Hetts SW , et al. Utility of MRI in spinal arteriovenous fistula. Neurology 2012; 79 (1) 25-30
• 67 Behrens S, Thron A. Long-term follow-up and outcome in patients treated for spinal dural arteriovenous fistula. J Neurol 1999; 246 (3) 181-185
• 68 Becker DA, Balcer LJ, Galetta SL. The Neurological Complications of Nutritional Deficiency following Bariatric Surgery. J Obes 2012; 2012: 608534